Lublin F, Miller DH, Freedman MS, et al. Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet 2016; 387: 1075–84—In this Article, the list of principal investigators in the appendix has been updated. This correction has been made to the online version as of Jan 19, 2017.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jEPv6S
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
A male aged 44 years presented to the emergency department with a 1-week history of intermittent right-sided abdominal pain radiating to the...
-
The National Health Service Five-Year Forward View delivery plan to tackle... Read more on AuntMinnieEurope.com Related Reading: RCR hi...
-
Related Articles Use of Mechanical Insufflation-Exsufflation Devices for Airway Clearance in Subjects With Neuromuscular Disease. Res...
-
The recent PNAS paper by Migliori et al. (1) attempts to explain the unusually strong temperature dependence of the bulk modulus of fcc plut...
-
The HiFocus Mid-Scala (MS) electrode array has recently been introduced onto the market. This precurved design with a targeted mid-scalar in...
-
ACS Nano DOI: 10.1021/acsnano.6b07865 from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jV1fyt via...
-
Clinical message from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2qNLv5e via IFTTT
-
Publication date: February 2017 Source: European Journal of Cancer, Volume 72 Author(s): Mark A. Applebaum, Zalman Vaksman, Sang Mee Lee, ...
-
Reproductive factors, hormones and colorectal cancer—still unresolved British Journal of Cancer 116, 1 (3 January 2017). doi:10.1038/bjc.20...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου